Temporary change in Polymer Factory’s management team 2025 – CEO takes parental leave

Mats Wallnér, board member of Polymer Factory Sweden AB (publ), will take over as acting CEO on 1 January 2025, when Elin Mignérus will take parental leave.

Starting January 1, 2025, Mats Wallnér will take over as acting CEO, as current CEO Elin Mignérus takes parental leave. Sharing management responsibility, Michael Malkoch will also take on increased operational duties within his role as CTO for the Company. Both Mats and Michael have previously held the CEO position at Polymer Factory, and being part of the founding team, they have great knowledge about the Company, technology, and business. 

Elin Mignérus, who took over as CEO in April 2021, plans to be on parental leave during 2025.

For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.